Related Experiment Videos
Azlocillin: a new broad spectrum penicillin.
The Journal of Antimicrobial Chemotherapy
|May 1, 1983
Summary
Azlocillin, a novel penicillin antibiotic, demonstrates broad-spectrum antibacterial activity, particularly against Pseudomonas aeruginosa. It maintains potency against Gram-positive and anaerobic bacteria, offering a valuable therapeutic option.
Area of Science:
- Microbiology
- Pharmacology
Background:
- Azlocillin is a new semisynthetic penicillin.
- It exhibits broad-spectrum antibacterial activity.
Purpose of the Study:
- To evaluate the antibacterial spectrum and characteristics of azlocillin.
- To compare its activity against resistant bacterial strains.
Main Methods:
- Assessing antibacterial activity against various bacterial pathogens.
- Evaluating susceptibility to beta-lactamases.
- Determining synergistic interactions with other antibiotics.
Main Results:
- High activity against Pseudomonas aeruginosa, including resistant strains.
- Potency against Gram-positive, fastidious Gram-negative, and anaerobic organisms.
- Susceptibility to certain beta-lactamases limits activity against resistant strains.
- Bactericidal effect on susceptible bacteria.
- Synergistic interactions with aminoglycosides against specific pathogens.
Conclusions:
- Azlocillin offers broad-spectrum efficacy, including against challenging Gram-negative pathogens.
- Its activity profile is distinct from other penicillins, with retained Gram-positive and anaerobic potency.
- Understanding beta-lactamase susceptibility is crucial for optimal use.